Kancera Stock: price and insider trades · Sweden
No insider purchase over the last 90 days. The latest, by Håkan Mellstedt, was filed 28 Aug 2020.
Kancera: what insiders have been doing
Every trade that managers of Kancera disclose to Finansinspektionen is tracked on this page. Nothing new has been filed by managers of Kancera in twelve months, the latest record being from 28 August 2020.
Looking back to 2017, when coverage begins, insiders filed 6 purchases and 4 sales.
Other companies in the same market with recent insider buying flagged by our signals: Dynavox Group AB and Rusta AB (publ). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Financial data
· cache
- 15,000 shares@ SEK 0.470.0% of flowInterimsaktieISIN SE0005935434FI:csv-601cabe0765bd2ba3ab5Canonical exit: 25 Nov 2020 (T+90)
- 30,000 shares@ SEK 0.390.0% of flowBTU (betald tecknad unit)ISIN SE0003622265FI:csv-802af0eb35a2c8d257c4Canonical exit: 16 Jun 2020 (T+90)
- 483 shares@ SEK 1.200.0% of flowISIN SE0003622265FI:csv-e73e70db9ad8be8022d5Canonical exit: 20 Aug 2018 (T+90)
- 25,000 shares@ SEK 1.200.0% of flowISIN SE0003622265FI:csv-855b45c9274e9cae6944Canonical exit: 20 Aug 2018 (T+90)
- 558,000 shares@ SEK 0.00410.0% of flowISIN SE0011178185FI:csv-d76f597f81b6e5ef441a
- 643,440 shares@ SEK 0.01640.0% of flowISIN SE0011178185FI:csv-fead7398e97b527398b0
- 1,387,000 sharesFI:csv-7312b22c3085d15c4dee
- 80,000 shares@ SEK 7,299.0023.3% of flowFI:csv-a949bfd5394e4b1c0d08Canonical exit: 14 Aug 2017 (T+90)
- 60,000 shares@ SEK 4,701.0011.3% of flowFI:csv-80fcf22c4ae341c981de
- 130,000 shares@ SEK 12,545.0065.4% of flowFI:csv-942f5e661e4fa4670d58Canonical exit: 13 Aug 2017 (T+90)
10 of 10 declarations
About Kancera
Kancera is a Swedish company focused on developing treatments for cancer and inflammatory diseases. It emphasizes research and innovation in the field of targeted therapies.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations